ALBT vs RENX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALBT exhibits severe financial distress, as evidenced by a Piotroski F-Score of 1/9, indicating extreme weakness in operational and financial health. The company reports a negative ROE of -4,129.79% and a negative Price/Book ratio of -0.17, signaling deep losses and asset erosion. With no meaningful profitability, negative cash flow indicators, and a current ratio of just 0.15, liquidity and solvency are critically impaired. The stock has declined over 99% in five years, reflecting sustained investor pessimism. Despite a modest gross margin of 35.65%, the company’s inability to generate sustainable earnings or positive cash flow undermines any potential for recovery.
RENX exhibits critical financial distress, anchored by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is facing a liquidity crisis with a Current Ratio of 0.12 and a Quick Ratio of 0.04, suggesting an inability to meet short-term obligations. Extreme leverage (Debt/Equity of 5.06) combined with a catastrophic ROE of -608.19% points toward a high risk of insolvency. Despite a superficial spike in Q/Q revenue growth, the long-term price performance (-99.9% over 5 years) and bearish technical trend (0/100) signal a failing enterprise.
Compare Another Pair
Related Comparisons
ALBT vs RENX: Head-to-Head Comparison
This page compares Avalon GloboCare Corp. (ALBT) and RenX Enterprises Corp. (RENX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.